Advertisement

Business Briefing / Pharmaceuticals

Roche completes Genentech deal

March 27, 2009|Times Wire Reports

Swiss pharmaceutical giant Roche said it had completed its $46.8-billion takeover of San Francisco biotech firm Genentech. Roche, which already held 55.7% of Genentech stock, said it acquired a further 37.5% of shares by the offer deadline Wednesday.

Advertisement
Los Angeles Times Articles
|
|
|